Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: ?
Life Threatening? No
Write-up: Left side pain in the throat; Abscess on the palate; Allergy in the skin, neck and face; This is a spontaneous report from a non-contactable consumer (patient) from the COVAES portal. A 66-year-old female patient received bnt162b2 (Pfizer-BioNTech COVID-19 vaccine), dose 1 administered in arm right on 02Jun2021 10:00 (Batch/Lot number was not reported) as 1st dose, single for covid-19 immunisation. Medical history included a hysterectomy and a tonsillectomy on an unknown date and known allergies (reported as "to many things"). The patient informed that she was diagnosed with COVID-19 Prior to vaccination. Concomitant medications received within 2 weeks of vaccination included clonazepam (unknown manufacturer), sertraline (unknown manufacturer), alprazolam (unknown manufacturer) and abrus precatorius, aconitum napellus, atropa belladonna, calendula officinalis, chelidonium majus, viburnum opulus (SEDA TIF PC); all of them taken for an unspecified indication, start and stop date were not reported. On 04Jun2021 18:30 the patient experienced left side pain in the throat, abscess on the palate, an allergy in the skin, neck and face; all this on 04Jun2021 and 06Jun2021 (reported as 2 and 4 days after the vaccination). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Since the vaccination, the patient had not been tested for COVID-19. The patient indicated that therapeutic measures were taken in response to the events, she received an injected antiallergic (decadron duo). The outcome for the events was unknown. Information of the lot/batch number has been requested.
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166